Live Webinar: What Self-Funded Employers Need to Know About TrumpRx, Mark Cuban’s CostPlusDrugs, and the new Oral GLP-1
Join RxSaveCard Founder and CEO, Chris Crawford, for a discussion on how recent developments in the cash pay marketplace are changing the game for self-funded employers. Direct pricing, transparent costs, easier access – employers save, employees save, everybody wins.
- Date/Time: Wed. February 11th, 2026 at 11am CT
- Duration: 30mins
- Can't attend live? Register anyway, and we'll send you the recording!
- Who Can Attend: Benefits professionals advising on or responsible for self-funded employee health plans
Meet Chris Crawford
Founder & CEO of RxSaveCard
Chris Crawford has always been driven by a simple question: Why should anyone overpay for prescriptions when lower prices are available? After 25+ years in the employee benefits space, he founded RxSaveCard as a solution to that problem.
Webinar Agenda:
How will TrumpRx and the new administration's drug pricing policies affect self-funded employers?
Understand how the new administration is approaching prescription drug pricing and what this means for GLP-1 access and employer costs.
How will the new oral GLP-1s impact an employer's prescription drug spend?
Discover how oral medications launched in January 2026 will make GLP-1s more accessible, drive utilization beyond current projections, and impact your budget.
What medications are available through Mark Cuban's CostPlusDrugs and other direct manufacturing programs?
Discover how pharmaceutical companies are bypassing insurance with transparent, self-pay programs and which medications are available at significantly cheaper, cash prices.
How do transparent cash prices impact an employer's fiduciary obligations?
Understand how access to lower-cost alternatives affects your responsibilities as a plan fiduciary and what it means for plan design decisions.
Interested, but can’t attend live? Register to also request access to the full webinar recording.